Nikolaοs Tentolouris

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.8K citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 612 citations · Full text

Medicine, Endocrinology, Nephrology +10

Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial

Bernard Zinman, Vanita R. Aroda, John B. Buse et al. · Diabetes Care · 2019 · 282 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic

Nikolaοs Tentolouris, Edward B. Jude, I. Smirnof et al. · Diabetic Medicine · 1999 · 221 citations

Veterinary Medicine, Infectious Diseases, Microbiology +17

Efficacy and Safety of IDegLira Versus Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes Uncontrolled on Metformin and Basal Insulin: The DUAL VII Randomized Clinical Trial

Liana K. Billings, Ankur Doshi, D. Gouet et al. · Diabetes Care · 2018 · 188 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17